IGIva GreyWolf

Iva GreyWolf

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Iva GreyWolf has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Aryeh L. Levenson

    From the Yale University School of Medicine (SSO, RWR, DR, JR, BM, RW), New Haven, CT; Southeast Regional Health Consortium (ALL, IGW, LEC), Alaska; Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism (CAH, DG), NIH, Rockville, Maryland; Bartlett Regional Hospital (VS), Alaska

    1 shared publication
  • Boris Meandzija

    From the Yale University School of Medicine (SSO, RWR, DR, JR, BM, RW), New Haven, CT; Southeast Regional Health Consortium (ALL, IGW, LEC), Alaska; Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism (CAH, DG), NIH, Rockville, Maryland; Bartlett Regional Hospital (VS), Alaska

    1 shared publication
  • Brenda A. Lee

    Institute for the Study of Race and Culture, Boston College

    1 shared publication
  • Carolyn Zerbe Enns

    Department of Psychology, Cornell University

    1 shared publication
  • Colin A. Hodgkinson

    From the Yale University School of Medicine (SSO, RWR, DR, JR, BM, RW), New Haven, CT; Southeast Regional Health Consortium (ALL, IGW, LEC), Alaska; Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism (CAH, DG), NIH, Rockville, Maryland; Bartlett Regional Hospital (VS), Alaska

    1 shared publication
  • David Goldman

    National Institute on Alcohol Abuse and Alcoholism

    1 shared publication

Latest Publications

  • Reclaiming love, wisdom, and healing through decolonial and liberation psychologies: A call to action.

    by Mercedes Santana, Gitika T., Thema Bryant, Lillian Comas-Díaz, Carolyn Zerbe Enns, Shelly P. Harrell, Liza Hita, Iva GreyWolf, Maryam Kia-Keating, B. Andi Lee, et al.

    This special issue, an outgrowth of Dr. Thema Bryant's 2023 American Psychological Association presidential initiatives, highlights the practical application of decolonial and liberation psychologies. Contributors to this issue address the diverse lived experiences of people of the Global Majority and prioritize the reclamation of epistemologies and perspectives that have been marginalized, excluded, or erased from most applications and practices of psychology. Following a brief introduction to decolonial and liberation psychologies, we express our gratitude to those who have inspired our dreams of new ways of doing psychology and also reflect on the challenging global crises and life challenges that have informed our editing and writing. We describe our decolonial editorial process that intentionally incorporated the humanizing, holistic, restorative, and communal values of liberating psychologies. Brief descriptions of the 16 articles in this special issue are organized around three interrelated themes-reclaiming love, reclaiming wisdom, and reclaiming healing-and articulate how these themes are applied across a range of healing, educational, and community settings that serve persons with diverse social identities across multiple regions around the globe. The entire project is rooted in the principles and values of decolonial and liberation psychologies, which we outline in a manifesto that reflects our guiding vision, serves as a call to action, and emphasizes healing practices infused with love, wisdom, joy, and inclusion. (PsycInfo Database Record (c) 2025 APA, all rights reserved).


  • Awakening Resilience: Recovery Within Intimate Female Friendships

    by Iva GreyWolf

    A multi-ethnic female creates her own definition of self with the help of strong female role models—women of strength. The author uses a storytelling method, characteristic Native American way of relating, as a vehicle for her narration. It is a story of transitions with challenges in relationships and new beginnings that define the woman as well as the therapist.


  • Naltrexone Alone and With Sertraline for the Treatment of Alcohol Dependence in Alaska Natives and Non‐Natives Residing in Rural Settings: A Randomized Controlled Trial

    by Stephanie S. O’mAlley, Robert W. Robin, Aryeh L. Levenson, Iva GreyWolf, Lawrence E. Chance, Colin A. Hodgkinson, Denise Romano, Jane Robinson, Boris Meandzija, Verner Stillner, et al.

    Background:  Access to specialty alcoholism treatment in rural environments is limited and new treatment approaches are needed. The objective was to evaluate the efficacy of naltrexone alone and in combination with sertraline among Alaska Natives and other Alaskans living in rural settings. An exploratory aim examined whether the Asn40Asp polymorphism of the μ‐opioid receptor gene (OPRM1) predicted response to naltrexone, as had been reported in Caucasians.Methods:  Randomized, controlled trial enrolling 101 Alaskans with alcohol dependence, including 68 American Indians/Alaska Natives. Participants received 16 weeks of either (1) placebo (placebo naltrexone + placebo sertraline), (2) naltrexone monotherapy (50 mg naltrexone + sertraline placebo) and (3) naltrexone + sertraline (100 mg) plus nine sessions of medical management and supportive advice. Primary outcomes included Time to First Heavy Drinking Day and Total Abstinence.Results:  Naltrexone monotherapy demonstrated significantly higher total abstinence (35%) compared with placebo (12%, p = 0027) and longer, but not statistically different, Time to First Heavy Drinking Day (p = 0.093). On secondary measures, naltrexone compared with placebo demonstrated significant improvements in percent days abstinent (p = 0.024) and drinking‐related consequences (p = 0.02). Combined sertraline and naltrexone did not differ from naltrexone alone. The pattern of findings was generally similar for the American Indian/Alaska Native subsample. Naltrexone treatment response was significant within the group of 75 individuals who were homozygous for OPRM1 Asn40 allele. There was a small number of Asp40 carriers, precluding statistical testing of the effect of this allele on response.Conclusions:  Naltrexone can be used effectively to treat alcoholism in remote and rural communities, with evidence of benefit for American Indians and Alaska Natives. New models of care incorporating pharmacotherapy could reduce important health disparities related to alcoholism.